Zalevsky Jonathan

NEKTAR THERAPEUTICS · Chief R&D Officer

Zalevsky Jonathan is listed in public filings as officer: Chief R&D Officer. This Zalevsky Jonathan insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include NEKTAR THERAPEUTICS (NKTR). Investors use Zalevsky Jonathan's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
NEKTAR THERAPEUTICSNKTR--199 sharesSellMay 19, 2026$13.0K199 shares$65.51$65.40

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Historical actions before the latest disclosure date will appear here after more snapshots are available.
Zalevsky Jonathan | TradingNote